BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4316120)

  • 21. Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
    Levantine A; Almeyda J
    Br J Dermatol; 1972 Jun; 86(6):651-5. PubMed ID: 4114691
    [No Abstract]   [Full Text] [Related]  

  • 22. [Side effects of antitubercular drugs leading to discontinuation of drug therapy].
    Bergan S; Laake K; Bjartveit K
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):279-82. PubMed ID: 7385151
    [No Abstract]   [Full Text] [Related]  

  • 23. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current views on drug treatment of tuberculosis].
    Repo K; Riska N
    Duodecim; 1970; 86(21):1268-78. PubMed ID: 5490929
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pregnancy and tuberculosis].
    Neumann G
    Med Klin; 1974 Oct; 69(40):1595-1601. PubMed ID: 4612309
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antitubercular therapy in pregnancy in relation to possible injurious effects on gestation and the fetus].
    Jotti D; Corato P; Cattini GC
    Arch Maragliano Patol Clin; 1968; 24(3):335-45. PubMed ID: 5755412
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of tuberculosis today in Nebraska.
    Burgher LW; Kass I
    Nebr Med J; 1973 May; 58(5):156-62. PubMed ID: 4348990
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental chemotherapy of tuberculosis].
    Krebs A
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 130(5):417-48. PubMed ID: 4899157
    [No Abstract]   [Full Text] [Related]  

  • 31. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 32. [Launois-Bensaude disease; etiopathogenic discussion in a patient treated with tuberculostatic agents].
    Warembourg H; Jaillard J; Carre A; Perrard C; Ginestet A; Beuscart F
    Lille Med; 1975 Feb; 20(2):102-6. PubMed ID: 1142984
    [No Abstract]   [Full Text] [Related]  

  • 33. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Liver function in tuberculosis treated with pyrazinamide, cycloserine, ethionamide and isoniazid].
    Uçak D; Uçak A
    Tip Fak Mecm; 1969; 32(1):48-52. PubMed ID: 5398987
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of tuberculous praevesical ureteral strictures (author's transl)].
    May P; Schindler E
    Urologe A; 1974 Jan; 13(1):1-5. PubMed ID: 4856813
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preliminary note on blood iron level changes in tuberculous patients treated with thioamides-isoniazid and rifomycin-isoniazid combinations].
    Guillermand J; Esvant J; Brand A; Etienne R
    Therapie; 1970; 25(1):137-41. PubMed ID: 5436796
    [No Abstract]   [Full Text] [Related]  

  • 38. [Signes of adaptation under long-term combined antituberculous therapy (author's transl)].
    Regli J; Ziegler WJ
    Schweiz Rundsch Med Prax; 1974 Jan; 63(2):49-50. PubMed ID: 4212815
    [No Abstract]   [Full Text] [Related]  

  • 39. [New findings concerning the biochemical mechanisms of the tuberculous process and the correction of biochemical abnormalities using etiopathogenetic preparations].
    Maliuk VI
    Probl Tuberk; 1984 Nov; (11):61-4. PubMed ID: 6395132
    [No Abstract]   [Full Text] [Related]  

  • 40. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.